FIBRESPIN is an innovative textile production machine, designed for producing spools of wool/cotton fibres. Thanks to our innovative design including use of high-tech materials, an innovative electro-magnetic braking system and advanced electronic control of the whole machine, FIBRESPIN will greatly reduce maintenance downtimes and component breakage (almost eliminated), as well as strongly boost productivity, outperforming existing machines (+52% outputs).
The feasibility study, conducted from September, 2015 to December, 2015, has been made to validate our approach to market as well as our technology, including a freedom to operate study and risk analysis. We have fully defined the technical specifications, prototype testing, financial forecasting of various production scenarios, and planning through full-scale production.
The first partner and coordinator of this project, Cognetex, based in Imola in Italy, have been manufacturing high quality textile machinery for over 60 years. Our 2015 turnover was ~€4.2million and we currently employ ~30 workers, providing machinery to ~270 customers throughout the world (i.e. EU, Asia, Middle East). In Cognetex we manufacture different types of machinery for the Textile industry. This ranges from our IDEA series of Worsted Ring Spinning Frames, used to spin individual wool fibres onto spools, to our Tow to Top Stretch Breaking Lines, which are designed for producing yarns, which are basically wools consisting of multi-fibres. All of our machines can also incorporate state-of-the-art hardware/software technology, making them fully automated and user-friendly systems.
The second partner, Elettronica GF, is an Italian hardware and software manufacturer based in Faenza, with turnover of €4.3million and 30 employees, to participate in this project as a partner to develop and exclusively supply the necessary hardware-software embedded systems in FIBRESPIN.
Key stakeholders and interesting end users, such as Embul Investment and Gazzetto, will participate in the testing and industrial validation.